Abstract

Multiple system atrophy (MSA) is a neurodegenerative disease caused by α-synuclein aggregation in oligodendrocytes and neurons. Using a transgenic mouse model overexpressing human α-synuclein in oligodendrocytes, we previously demonstrated that oligodendrocytic α-synuclein inclusions induce neuronal α-synuclein accumulation and progressive neuronal degeneration. α-Synuclein binds to β-III tubulin, leading to the neuronal accumulation of insoluble α-synuclein in an MSA mouse model. The present study demonstrates that α-synuclein co-localizes with β-III tubulin in the brain tissue from patients with MSA and MSA model transgenic mice as well as neurons cultured from these mice. Accumulation of insoluble α-synuclein in MSA mouse neurons was blocked by the peptide fragment β-III tubulin (residues 235-282). We have determined the α-synuclein-binding domain of β-III tubulin and demonstrated that a short fragment containing this domain can suppress α-synuclein accumulation in the primary cultured cells. Administration of a short α-synuclein-binding fragment of β-III tubulin may be a novel therapeutic strategy for MSA.

Highlights

  • Neuronal and oligodendrocytic aggregation of insoluble ␣-synuclein contributes to neuropathology in multiple system atrophy

  • We previously demonstrated that ␣-syn binds to ␤-III tubulin, leading to neuronal accumulation of insoluble ␣-syn and neurodegeneration in an Multiple system atrophy (MSA) mouse model [10, 12, 13]

  • The present study showed that ␣-syn co-localizes with ␤-III tubulin in the brain tissues of patients with MSA

Read more

Summary

Background

Neuronal and oligodendrocytic aggregation of insoluble ␣-synuclein contributes to neuropathology in multiple system atrophy. The exogenous ␣-syn in oligodendrocytes was of human origin, and the endogenous ␣-syn in neurons was of mouse origin in the mouse CNS These Tg mice recapitulated many features of MSA neuropathology and provided evidence that formation of GCIs triggers neuronal accumulation of insoluble ␣-syn, leading to neuronal dysfunction and degeneration in the mouse CNS [10, 12, 13]. This is consistent with the neuronal pathology in the human pathology of MSA [14]. This study suggests an alternative treatment strategy for MSA, inhibiting ␣-syn1⁄7␤-III tubulin complex formation to suppress insoluble ␣-syn accumulation in neurons

EXPERIMENTAL PROCEDURES
RESULTS
B ThT spinal cord
A COS-7 cells
B Syn β-III tubulin Merge
E Mouse α-syn
Findings
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call